![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1517327
¼¼°èÀÇ ½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀå ±Ô¸ð Á¶»ç : Á¦Ç°º°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° ¿¹Ãø(2022-2032³â)Global Nephrology and Urology Devices Market Size Study, by Product Type, by Application, by End User and Regional Forecasts 2022-2032 |
¼¼°è ½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀåÀº 2023³â 327¾ï 1,000¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç, 2023-2032³â ¿¹Ãø ±â°£ µ¿¾È 4.5% ÀÌ»óÀÇ °ßÁ¶ÇÑ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀåÀº ÁÖ·Î ¸¸¼º ½ÅÀå Áúȯ(CKD)°ú ¸»±â ½ÅÀå Áúȯ(ESRD)ÀÇ À¯º´·ü Áõ°¡¿¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ¹Ì±¹ Áúº´¿¹¹æÅëÁ¦¼¾ÅÍ(CDC)¿¡ µû¸£¸é, ¸¸¼ºÄáÆÏº´ À¯º´·üÀº ³²¼º(12%)¿¡ ºñÇØ ¿©¼º(14%)ÀÌ ´Ù¼Ò ³ôÀº °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. ±× °á°ú, ½ÅÀå Áúȯ ¹× ±âŸ ºñ´¢±â°ú ÁúȯÀÇ À¯º´·ü Áõ°¡´Â ½ÅÀåÇÐ ¹× ºñ´¢±â°ú Àåºñ¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½ÃÄÑ ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½ÅÀå ¹× ºñ´¢±â°ú ÁúȯÀÇ Á¶±â Áø´Ü ¹× Ä¡·áÀÇ Á߿伺¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼ ¼±º° ¹× Áø´Ü Àåºñ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ¿© ½ÅÀåÇÐ Àåºñ ½ÃÀåÀÇ ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¹Ì±¹ ½ÅÀå ±â±Ý(American Kidney Fund)Àº ¸¸¼º ½ÅÀå Áúȯ °ËÁøÀÇ È°¿ëÀ» È®´ëÇϰí Èñ±Í ½ÅÀå ÁúȯÀÇ Áø´Ü°ú ¿¹¹æÀ» °³¼±Çϱâ À§ÇÑ ÀÓ»ó ¿¬±¸, ÀÇ·áÁø ±³À°, Èñ±Í ½ÅÀå Áúȯ Áø´Ü ¹× ¿¹¹æ Á¤Ã¥À» Áö¿øÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀçÅà Åõ¼® ¼Ö·ç¼Ç ¹× ÈÞ´ë¿ë ÀåÄ¡¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀå ¼ºÀå¿¡ À¯¸®ÇÑ ±âȸ¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù.
¸¸¼º ½ÅÀå Áúȯ, ½ÅÀå °á¼®, ¿ä½Ç±Ý, ºñ´¢±â¾Ï°ú °°Àº ÁúȯÀÇ ¹ßº´·ü Áõ°¡·Î ÀÎÇØ ½ÅÀå ¹× ºñ´¢±â ÀåÄ¡ ¹× Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â ºÐ¼® ±â°£ µ¿¾È ½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀÔ´Ï´Ù. ¶ÇÇÑ ÃÖ¼Òħ½À ¼ö¼ú±â±¸, ·Îº¿ º¸Á¶ ¼ö¼ú, Áø´Ü µµ±¸ÀÇ °³¼± µî ÀÇ·á±â±âÀÇ Áö¼ÓÀûÀÎ ±â¼ú Çõ½ÅÀº ȯÀÚ Ä¡·á °á°ú¸¦ °³¼±ÇÏ°í ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ÇÁ·¹Á¦´Ï¿ì½º ¸ÞµðÄà Äɾî(Fresenius Medical Care)ÀÇ 6008 ½Ã¸®Áî Ç÷¾× Åõ¼®±â´Â Á¤È®ÇÑ Åõ¼® Ä¡·á¸¦ À§ÇÑ Ã·´Ü ±â´ÉÀ» Á¦°øÇÏ¿© ȯÀÚ¿Í ÀÇ·áÁø ¸ðµÎ¿¡°Ô Åõ¼® °æÇèÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀº ½ÅÀå ¹× ºñ´¢±â ±â±â ½ÃÀåÀÇ ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ºñ´¢±â°ú ±â±â´Â °í°¡À̱⠶§¹®¿¡ ƯÈ÷ ¾Æ½Ã¾ÆÅÂÆò¾ç°ú °°ÀÌ °¡°Ý¿¡ ¹Î°¨ÇÑ Áö¿ª¿¡¼´Â ½ÃÀå ¼ºÀå¿¡ ºÎÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ºñ´¢±â ³»½Ã°æ°ú ¿£µåºñÀü ½Ã½ºÅÛÀÇ ³ôÀº ºñ¿ëÀº ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ºñ´¢±â°ú ±â±â¸¦ Á¶ÀÛÇϰí À¯Áöº¸¼öÇÒ ¼ö ÀÖ´Â ¼÷·ÃµÈ Àü¹®°¡°¡ ºÎÁ·ÇÏ´Ù´Â Á¡µµ ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â Áß¿äÇÑ ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.
½ÅÀå ¹× ºñ´¢±â ±â±â ¼¼°è ½ÃÀå Á¶»ç¿¡¼ °í·ÁµÈ ÁÖ¿ä Áö¿ªÀº ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÔ´Ï´Ù. ºÏ¹Ì´Â 2023³â ¸ÅÃâ ±âÁØÀ¸·Î ½ÃÀåÀ» Áö¹èÇϰí ÀÖ½À´Ï´Ù. ÀÌ´Â ÁÖ·Î ¼±ÁøÈµÈ ÀÇ·á ÀÎÇÁ¶ó, ½ÅÀå ¹× ¿ä·Î ÁúȯÀÇ ³ôÀº À¯º´·ü, ¿¬±¸°³¹ß¿¡ ´ëÇÑ ¸·´ëÇÑ ÅõÀÚ¿¡ ±âÀÎÇÕ´Ï´Ù. ÀÌ Áö¿ªÀº ÀÇ·á ½Ã¼³ÀÌ Àß °®Ãß¾îÁ® ÀÖ°í ¼÷·ÃµÈ ÀÇ·á ÀηÂÀ» º¸À¯Çϰí ÀÖ¾î Çõ½ÅÀûÀÎ ½ÅÀå ¹× ºñ´¢±â Ä¡·á Àåºñ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ƯÈ÷ ¹Ì±¹Àº ¸¸¼ºÄáÆÏº´(CKD)°ú ºñ´¢±â ÁúȯÀÇ ³ôÀº ¹ßº´·ü°ú °í±Þ Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ ¼ö¿ä·Î ½ÃÀåÀ» ¼±µµÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, À¯¸®ÇÑ »óȯ Á¤Ã¥°ú Á¤ºÎ ¹× ¹Î°£ ÀÇ·á±â°üÀÇ °·ÂÇÑ Áö¿øÀÌ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÁÖ¿ä ÀÇ·á±â±â Á¦Á¶¾÷üÀÇ Á¸Àç¿Í Áö¼ÓÀûÀÎ ±â¼ú ¹ßÀüÀº ÀÌ Áö¿ªÀÇ ½ÃÀå Áö¹è·ÂÀ» ´õ¿í °ÈÇϰí ÀÖ½À´Ï´Ù. ½ÅÀå ¹× ºñ´¢±â ÁúȯÀÇ Á¶±â Áø´Ü ¹× Ä¡·á¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í °í·ÉÈ »çȸ·Î Á¢¾îµé¸é¼ ºÏ¹ÌÀÇ ½ÅÀå ¹× ºñ´¢±â ±â±â ¼ö¿ä Áõ°¡¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¾Æ½Ã¾ÆÅÂÆò¾çÀº 2024-2032³â ¿¹Ãø ±â°£ µ¿¾È Å« ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
The Global Nephrology and Urology Devices Market was valued at USD 32.71 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 4.5% over the forecast period 2023-2032. The market for nephrology and urology devices is primarily driven by the increasing prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD). According to the Centers for Disease Control and Prevention (CDC), chronic kidney disease is slightly more prevalent in women (14%) compared to men (12%). Consequently, the growing incidence of kidney diseases and other urological conditions has increased the demand for nephrology and urology devices, thereby propelling market growth during the forecast period. Additionally, increased awareness of the importance of early diagnosis and treatment of kidney and urology disorders has led to higher demand for screening and diagnostic devices, further driving the nephrology devices market growth. The American Kidney Fund supports policies to expand the use of chronic kidney disease screening and improve clinical research, provider training, and diagnosis and prevention of rare kidney diseases. Furthermore, the increasing demand for home-based dialysis solutions and portable devices provides a lucrative opportunity for the nephrology and urology devices market growth.
The rise in the incidence of conditions such as chronic kidney disease, kidney stones, urinary incontinence, and urological cancers has created a high demand for devices and treatments in nephrology and urology. This trend drives market growth during the nephrology and urology devices market analysis period. Furthermore, ongoing innovations in medical devices, such as minimally invasive surgical instruments, robotic-assisted surgeries, and improved diagnostic tools, have enhanced patient outcomes and boosted market growth. For example, Fresenius Medical Care's 6008 Series Hemodialysis Machines offer advanced features for precise dialysis treatment, enhancing the overall dialysis experience for both patients and healthcare providers. These advancements have fueled the growth of the nephrology and urology devices market. However, the high cost of urology devices negatively impacts market growth, particularly in price-sensitive regions such as Asia-Pacific. The high cost of urology endoscopes and endovision systems may hamper market growth. In addition, the lack of skilled professionals to operate and maintain urology devices is a significant factor that may restrain market growth.
The key regions considered for the Global Nephrology and Urology Devices Market study include North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America dominates the market in 2023 in terms of revenue. This is primarily due to its advanced healthcare infrastructure, high prevalence of kidney and urinary tract diseases, and significant investment in research and development. The region's well-established healthcare facilities and the availability of skilled healthcare professionals drive the demand for innovative nephrology and urology devices. The United States, in particular, leads the market with its high incidence of chronic kidney disease (CKD) and urological disorders, necessitating advanced treatment options. Additionally, favorable reimbursement policies and strong support from government and private healthcare organizations boost market growth. The presence of major medical device manufacturers and continuous technological advancements further enhance the region's market dominance. Increasing awareness about early diagnosis and treatment of kidney and urinary conditions, along with a growing aging population, also contribute to the rising demand for nephrology and urology devices in North America. Furthermore, Asia Pacific is projected to grow significantly during the forecast period 2024-2032.